secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cidara Therapeutics, Inc. (—)
CIK:        0001610618
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001610618-23-000102
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cidara receives Nasdaq delisting notice for bid price below $1.00; requests hearing
--------------------------------------------------------------------------------

- Nasdaq notified Cidara on Nov 9, 2023 that bid price closed below $1.00 for 30 consecutive trading days.
- Company is not eligible for compliance period due to prior Panel Monitor imposed by Nasdaq.
- Cidara requested a hearing on Nov 16, 2023 to present a compliance plan and seek additional time.
- Hearing request stays delisting action until Panel renders a decision.
- No assurance that Panel will grant the requested 180-day extension or the hearing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610618/000161061823000102/0001610618-23-000102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610618/000161061823000102/cdtx-20231109.htm
  HTML page:      https://secwatch.observer/filing/0001610618-23-000102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer